Botswana Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports

Botswana Pharmaceuticals and Healthcare Report

Botswana Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports
Botswana Pharmaceuticals and Healthcare Report
Published Jul 23, 2016
54 pages — Published Jul 23, 2016
Price US$ 1,295.00  |  Buy this Report Now

About This Report

  
Abstract:

Botswana s pharmaceutical expenditure is forecast to grow from BWP-.--bn (USD---mn) in ---- to BWP-.--bn (USD---mn) in ----. Over the medium-term, pharmaceutical spending is forecast to increase to BWP-.--bn (USD---mn) in ----, corresponding to a compound annual growth rate (CAGR) of -.- in local currency terms and -.- in US dollar terms. ...Botswana s pharmaceutical expenditure is forecast to grow from BWP-.--bn (USD---mn) in ---- to BWP-.--bn (USD---mn) in ----. Over the medium-term, pharmaceutical spending is forecast to increase to BWP-.--bn (USD---mn) in ----, corresponding to a compound annual growth rate (CAGR) of -.- in local currency terms and -.- in US dollar terms. By ----, the market will be valued at BWP-.--bn (USD---mn), equating to a local currency CAGR of -.- (-.- in US dollar terms). ...By ----, per capita sales are forecast to reach USD---.

...BMI View: Multinational drugmaker presence in Botswana will be limited to imports as the small market size and lack of investment incentives deter any large-scale investment plans. Although generic drugs will retain their dominance in terms of market share, as the burden of non-communicable diseases increases this will create more lucrative opportunities for foreign drugmakers. ...BMI View: Multinational drugmaker presence in Botswana will be limited to imports as the small market size and lack of investment incentives deter any large-scale investment plans. Although generic drugs will retain their dominance in terms of market share, as the burden of non-communicable diseases increases this will create more lucrative opportunities for foreign drugmakers. The government will remain committed to reducing the longstanding HIV/AIDS burden in the country. ...The government will remain committed to reducing the longstanding HIV/AIDS burden in the country. As such, a combination of funding from the public sector and international donors will make significant progression towards achieving the UNAIDS -------- targets.

...Botswana remains the least corrupt nation in Sub-Saharan Africa following sound legal institutions and anti-corruption initiatives. The southern African nation held its rank as the least corrupt country in the region for the --th consecutive year as rated by Transparency International. ...

  
Source:
Document ID
2049-2421
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Business Monitor International - Industry Reports—Established in 1984, Business Monitor International is a leading online publisher of specialist business information on global emerging markets. Business Monitor's range of quarterly services covers political risk, finance, macroeconomic performance, outlook and forecast, industry sectors and the business operating environment. Each Industry Report has been researched at source, and features latest-available data covering production, sales, imports and exports; 5-year industry forecasts through end-2012; company rankings and competitive landscapes for multinational and local manufacturers and suppliers; and analysis of latest industry developments, trends and regulatory changes.

About the Author


Cite this Report

  
MLA:
Business Monitor International - Industry Reports. "Botswana Pharmaceuticals and Healthcare Report" Jul 23, 2016. Alacra Store. Dec 07, 2016. <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/Botswana-Pharmaceuticals-and-Healthcare-Report-2026-1276>
  
APA:
Business Monitor International - Industry Reports. (2016). Botswana Pharmaceuticals and Healthcare Report Jul 23, 2016. New York, NY: Alacra Store. Retrieved Dec 07, 2016 from <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/Botswana-Pharmaceuticals-and-Healthcare-Report-2026-1276>
  
US$ 1,295.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.